Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

H2L5186303, Tocris Bioscience™

Catalog Number 487810
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
139262-76-3
C26H20N2O8
488.452
HZFPOTBCYPWQSH-DZDAAMPGSA-N
z,z-4,4'-1,3-phenylenebis oxy-4,1-phenyleneimino bis 4-oxo-2-butenoic acid, 2z-3-4-3-4-2z-3-carboxyprop-2-enamido phenoxy phenoxy phenyl carbamoyl prop-2-enoic acid
90488981
(Z)-4-[4-[3-[4-[[(Z)-3-carboxyprop-2-enoyl]amino]phenoxy]phenoxy]anilino]-4-oxobut-2-enoic acid
C1=CC(=CC(=C1)OC2=CC=C(C=C2)NC(=O)C=CC(=O)O)OC3=CC=C(C=C3)NC(=O)C=CC(=O)O
This item is not returnable. View return policy
139262-76-3
C26H20N2O8
488.452
HZFPOTBCYPWQSH-DZDAAMPGSA-N
z,z-4,4'-1,3-phenylenebis oxy-4,1-phenyleneimino bis 4-oxo-2-butenoic acid, 2z-3-4-3-4-2z-3-carboxyprop-2-enamido phenoxy phenoxy phenyl carbamoyl prop-2-enoic acid
90488981
(Z)-4-[4-[3-[4-[[(Z)-3-carboxyprop-2-enoyl]amino]phenoxy]phenoxy]anilino]-4-oxobut-2-enoic acid
C1=CC(=CC(=C1)OC2=CC=C(C=C2)NC(=O)C=CC(=O)O)OC3=CC=C(C=C3)NC(=O)C=CC(=O)O

Potent and selective LPA2 receptor antagonist

Potent and selective lysophosphatidic acid 2 (LPA2) receptor antagonist (IC50 values are 8.9, 1230 and 27354 nM for LPA2, LPA3 and LPA1 receptors respectively, in a LPA-elicited calcium mobilization assay).
Quantity 10 mg
Formula Weight 488.45
Percent Purity >98%
Chemical Name or Material H2L5186303
Recommended Storage Store at +4°C
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit